Phase
Condition
Tourette's Syndrome
Schizotypal Personality Disorder (Spd)
Schizophrenia And Schizoaffective Disorders (Pediatric)
Treatment
iTEST
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Voluntary informed consent to participate and capacity to consent as measured by theUCSD Brief Assessment of Capacity to Consent (UBACC)
Age 18 to 65;
DSM-5 diagnosis of schizophrenia or schizoaffective disorder based on a structureddiagnostic interview and available medical record review;
≥ 6th grade reading level on the Wide Range Achievement Test-4 Reading subtest (needed to read instructions on device);
Stable co-treatments (no hospitalizations or medication class changes in 2 monthsbefore enrollment). The investigators will determine symptom and medicationstability by best-estimate history with information from medical records;
Availability of a clinician (staff member, case manager, other mental healthclinician) or close associate (family member, friend) with at least monthly contactwho can be their informant
Minimum level of functional impairment based on milestones, excluding participantswho are full-time employed and financially responsible for their household.
Exclusion
Exclusion Criteria:
Greater than moderate disorganization on the Positive and Negative Syndrome Scale (P2-Disorganization item >5)
DSM-5 alcohol or substance dependence in past 3 months based on interview
Level of care required interferes with outpatient therapy (e.g., hospitalized;severe medical illness); 4) Unable to adequately see or manually manipulate asmartphone.
Study Design
Study Description
Connect with a study center
University of California, San Diego
La Jolla, California 92037
United StatesActive - Recruiting
University of Texas at Dallas
Richardson, Texas 75080
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.